Thanks to close cooperation between Bart van de Warrenburg (Neurology) and Erik-Jan Kamsteeg (Genetics) two new genes involved in movement disorders were identified. The genes are relevant for autosomal recessive cerebellar ataxia. They published their findings with their co-workers in Brain and Annals of Neurology.The genes, previously not associated with human disease, were identified via clinical exome sequencing in patients that visited the Radboudumc expert centre for genetic movement disorders. Mutations in VPS13D were identified in 4 patients and an additional 8 patients were tracked by US and German collaborators.
This gene, which acts within the mitochondrial pathway, is probably a relevant gene for patients with movement disorders. While the Nijmegen patients showed features within the ataxia and spasticity spectrum, a back-to-back publication reported on a series of patients with hyperkinetic movement disorders caused by VPS13D mutations.
Cellular stressMutations in the second gene, GDAP2, were identified in a patient with a new ataxia phenotype. A second patient with this rare form of ataxia was found by Belgian partners in the E-rare/H2020 consortium PREPARE. Ilse Eidhof, PhD student in the Drosophila models of brain disorders group led by Annette Schenck, demonstrated that GDAP2 mutations lead to motor defects and reduced lifespan in Drosophila, resembling hallmarks of the human disorder. This work further suggested that GDAP2 pathology may result from altered responses to cellular stress.
Link to full publications:
Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects, Annals of neurology.
GDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia, Brain.
Related news items
Step-up approach vs open necrosectomy for necrotizing pancreatitis18 April 2019
Another publication of the successful Dutch collaborative group on pancreatitis research with substantial contribution from Radboudumc researchers, Harry van Goor and Kees van Laarhoven.read more
Prophylactic antibiotics reduce hospitalisations and cost in head and neck cancer patients18 April 2019
In European journal of cancer Janneke Ham and colleagues showed that prophylactic antibiotics in locally advanced head and neck cancer patients treated with chemoradiotherapy did not reduce the incidence of (aspiration) pneumonias, but did reduce hospitalisations and tended to be cost-effective.read more
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more
EU funded project BIOMAP led by Ellen van den Bogaard12 April 2019
Ellen van den Bogaard, theme Inflammatory diseases, leads the research on the experimental validation and functional analysis of identified biomarkers by using advanced organotypic skin models and receives a grant of €258,000.read more